ORICARE Revenue and Competitors
Estimated Revenue & Valuation
- ORICARE's estimated annual revenue is currently $2.5M per year.
- ORICARE's estimated revenue per employee is $251,000
Employee Data
- ORICARE has 10 Employees.
- ORICARE grew their employee count by 11% last year.
ORICARE's People
Name | Title | Email/Phone |
---|---|---|
1 | Product Specialist cum Service Manager (India Head) (Oricare Inc, Aeonmed Co. Ltd & Heyer AG) | Reveal Email/Phone |
ORICARE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 293 | 12% | N/A | N/A |
#2 | $7M | 28 | -10% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 37 | -10% | N/A | N/A |
#6 | $56.2M | 179 | 0% | N/A | N/A |
#7 | $38.9M | 155 | -1% | N/A | N/A |
#8 | $22.1M | 88 | 5% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is ORICARE?
ORICARE Inc. is a US-based manufacturer of OR and ICU medical devices. Since 2009, we have been leading innovators of healthcare solutions. Our product line ranges from Anesthesia Workstations, Critical Care Ventilators, Operating Tables, Surgical Lights, Pendants, Monitors, and much more.
keywords:N/AN/A
Total Funding
10
Number of Employees
$2.5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ORICARE News
... which Conclude Growth Factors, Analysis, Outlook and Forecast to 2027 | Amcaremed Technology, Sostel, BiHealthcare, Oricare, Pegisdan.
... Covers in Research Report with Latest Updates and Forecast to 2027 | Amcaremed Technology, Sostel, BiHealthcare, Oricare, Pegisdan.
Hersill, Spacelabs Healthcare, HEYER Medical, Siriusmed, Oricare, Biobase, Fritz Stephan, Mindray, GE Healthcare, Comen, Siare, DRE Medical, Dixion,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | 0% | N/A |
#2 | $2M | 16 | -6% | N/A |
#3 | $2.2M | 16 | -80% | N/A |
#4 | $2.1M | 21 | -5% | N/A |
#5 | $1.8M | 26 | -21% | N/A |